Results 161 to 170 of about 79,111 (213)

Intracellular control of renin release - an overview [PDF]

, 1986
Kurtz, Armin
core   +1 more source

Duloxetine and Angiotensin II Receptor Blocker Combination Potentially Induce Severe Hyponatremia in an Elderly Woman. [PDF]

Intern Med, 2019
Takayama A, Nagamine T, Matsumoto Y, Nakamura M.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Angiotensin-II Receptor Blockers

Archives of Internal Medicine, 2000
As described in the previous chapter, the renin-angiotensin system (RAS) plays an important role in the body’s regulation of arterial blood pressure. The effector hormone of the RAS is angiotensin II, which maintains the systemic vascular resistance and extracellular fluid volume through its direct and indirect vasoconstrictive and blood volume ...
William H. Frishman, Angela Cheng-Lai, Julie Chen   +2 more
openaire   +3 more sources

Olmesartan medoxomil: An angiotensin II-receptor blocker

Clinical Therapeutics, 2003
Regulation of the activity of the renin-angiotensin-aldosterone system has become important in the management of cardiovascular disease. Olmesartan medoxomil (CS-866) is the newest selective angiotensin II-receptor blocker (ARB) to be approved for the treatment of hypertension.This review describes the mechanism of action, pharmacokinetics, adverse ...
Julie A, Brousil, John M, Burke
openaire   +2 more sources

Candesartan cilexetil: An angiotensin II-receptor blocker

American Journal of Health-System Pharmacy, 2000
The mechanism of action, pharmacokinetics, pharmacodynamics, clinical efficacy, and adverse effects of candesartan cilexetil are reviewed. Candesartan is an angiotensin II-receptor blocker (ARB). It is administered as a pro-drug that undergoes activation during gastrointestinal absorption.
S, See, A L, Stirling
openaire   +2 more sources

Candesartan Cilexetil: An Angiotensin II Receptor Blocker

Annals of Pharmacotherapy, 1999
OBJECTIVE: To summarize and critique the medical literature on candesartan cilexetil, an angiotensin II receptor blocker (ARB). DATA SOURCES: MEDLINE searches (January 1966–January 1999) and manufacturer prescribing literature were used to identify articles on candesartan cilexetil. Bibliographies were also reviewed for germane articles.
C A, Stoukides, H J, McVoy, A F, Kaul
openaire   +2 more sources

Angiotensin II Receptor Blockers in Congestive Heart Failure

Cardiology in Review, 2006
The benefits of angiotensin-converting enzyme (ACE) inhibitors for the treatment of congestive heart failure (CHF) are well-established. A newer class of medications, angiotensin II receptor blockers (ARBs), may be a suitable replacement for ACE inhibitors as a result of a more complete inhibition of angiotensin II and better tolerability among ...
Mark J, Eisenberg, Laura C, Gioia
openaire   +2 more sources

Angiotensin II Receptor Blockers

2014
The angiotensin II receptor blockers (ARBs) inhibit the activity of angiotensin II at the angiotensin II receptor level (AT-1, AT-2 receptors). Losartan potassium is the prototype of the ARBs. Others are candesartan, irbesartan, valsartan, telmisartan, olmesartan, eprosartan, and azilsartan.
Esen Özkaya, Kurtuluş Didem Yazganoğlu   +1 more
openaire   +1 more source

Angiotensin II Receptor Blocker Induced Fetopathy: 7 Cases

Klinische Pädiatrie, 2011
During a period of 12 months 7 newborns with a partially severe fetopathy caused most probably by maternal sartan-intake in pregnancy were treated in 5 German teaching hospitals. Sartans antagonize the effect of angiotensin II at the AT1-receptor and are used to treat arterial hypertension.We presented 2 cases at the yearly GNPI meeting 2010 and we ...
C, Hünseler, A, Paneitz, D, Friedrich, U, Lindner, A, Oberthuer, F, Körber, K, Schmitt, L, Welzing, A, Müller, P, Herkenrath, B, Hoppe, L, Gortner, B, Roth, E, Kattner, T, Schaible   +14 more
openaire   +2 more sources